Retraction Note: Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
Crossref DOI link: https://doi.org/10.1038/s41698-021-00217-9
Published Online: 2021-08-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
La, V.
Fujikawa, R.
Janzen, D. M.
Nunez, M.
Bainvoll, L.
Hwang, L.
Faull, K.
Lawson, G.
Memarzadeh, S.
Text and Data Mining valid from 2021-08-09
Version of Record valid from 2021-08-09
Article History
First Online: 9 August 2021